NO20061306L - Modulating compounds of P-selectin glycoprotein ligand 1 - Google Patents

Modulating compounds of P-selectin glycoprotein ligand 1

Info

Publication number
NO20061306L
NO20061306L NO20061306A NO20061306A NO20061306L NO 20061306 L NO20061306 L NO 20061306L NO 20061306 A NO20061306 A NO 20061306A NO 20061306 A NO20061306 A NO 20061306A NO 20061306 L NO20061306 L NO 20061306L
Authority
NO
Norway
Prior art keywords
modulating compounds
glycoprotein ligand
selectin glycoprotein
selectin
ligand
Prior art date
Application number
NO20061306A
Other languages
Norwegian (no)
Inventor
Rong-Hwa Lin
Chung Nan Chang
Original Assignee
Abgenomics Coop U A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Abgenomics Coop U A filed Critical Abgenomics Coop U A
Publication of NO20061306L publication Critical patent/NO20061306L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20061306A 2003-09-15 2006-03-23 Modulating compounds of P-selectin glycoprotein ligand 1 NO20061306L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1
PCT/US2004/029520 WO2005027831A2 (en) 2001-08-03 2004-09-09 Modulators of p-selectin glycoprotein ligand 1

Publications (1)

Publication Number Publication Date
NO20061306L true NO20061306L (en) 2006-06-14

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061306A NO20061306L (en) 2003-09-15 2006-03-23 Modulating compounds of P-selectin glycoprotein ligand 1

Country Status (16)

Country Link
EP (1) EP1663290A4 (en)
JP (1) JP5808879B2 (en)
KR (1) KR101159140B1 (en)
CN (1) CN1852730B (en)
AU (1) AU2004273807B2 (en)
BR (1) BRPI0414402A (en)
CA (1) CA2538284C (en)
EC (1) ECSP066507A (en)
IL (1) IL174172A (en)
NO (1) NO20061306L (en)
NZ (1) NZ546203A (en)
RU (1) RU2407539C2 (en)
SG (1) SG146670A1 (en)
TW (2) TW201012472A (en)
UA (1) UA91004C2 (en)
ZA (1) ZA200602151B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751300B1 (en) * 2004-05-11 2017-11-08 AbGenomics Coöperatief U.A. T-cell death-inducing epitopes
WO2009139459A1 (en) * 2008-05-15 2009-11-19 国立大学法人 岡山大学 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
CN108713026B (en) * 2016-01-08 2023-01-06 美国全心医药生技股份有限公司 Tetravalent anti-PSGL-1 antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ZA973051B (en) * 1996-04-24 1998-10-12 Genentech Inc Type c lectins
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Also Published As

Publication number Publication date
ECSP066507A (en) 2006-10-10
TW201012472A (en) 2010-04-01
KR101159140B1 (en) 2012-06-22
RU2006112399A (en) 2006-08-10
JP5808879B2 (en) 2015-11-10
JP2007533618A (en) 2007-11-22
EP1663290A2 (en) 2006-06-07
CA2538284A1 (en) 2005-03-31
IL174172A0 (en) 2006-08-01
RU2407539C2 (en) 2010-12-27
TW200513262A (en) 2005-04-16
ZA200602151B (en) 2013-08-28
AU2004273807B2 (en) 2011-06-09
AU2004273807A1 (en) 2005-03-31
CA2538284C (en) 2015-10-20
IL174172A (en) 2011-12-29
CN1852730B (en) 2012-05-30
CN1852730A (en) 2006-10-25
SG146670A1 (en) 2008-10-30
EP1663290A4 (en) 2009-07-01
UA91004C2 (en) 2010-06-25
NZ546203A (en) 2009-05-31
TWI359024B (en) 2012-03-01
KR20060088104A (en) 2006-08-03
BRPI0414402A (en) 2006-11-14

Similar Documents

Publication Publication Date Title
DE602004031875D1 (en) CB1 MODULATOR COMPOUNDS
DE60210782D1 (en) GLUCOCINASE INFLUENTING COMPOUNDS
DE60304290D1 (en) Anti-siphon
SI2264172T1 (en) Oligomeric compounds for the modulation of hif-1alpha expression
DE60204105D1 (en) Heat-compatible seal
DE602004013730D1 (en) LIP SEAL
FI20010019A (en) Procedure for the diagnosis of atrophic gastritis
NO20055612D0 (en) Anti-inflammatory phosphonate compounds
DE60326633D1 (en) PHOSPHORESCENCE COMPOUND AND ELECTROLUMINESCENE ELEMENT CONTAINING THEREOF
NO20034301D0 (en) Cyano-substituted dihydropyrimidine compounds
DE60204737D1 (en) Continuous mud dispenser
NO20061306L (en) Modulating compounds of P-selectin glycoprotein ligand 1
ATE409689T1 (en) CIS-TRANS ISOMERIZATION OF SEMICARBAZONE COMPOUNDS
NO20044050L (en) Process for the synthesis of chiral N-aryl-piperazines
DE60331513D1 (en) Color filter substrate
DE60228478D1 (en) ARYL-ANNULATED AZAPOLYCYCLIC COMPOUNDS
DE10390373D2 (en) phosphorus compounds
NO20033191D0 (en) color modulator
ATE394370T1 (en) MONOHALOVINYL COMPOUNDS DERIVED FROM VITAMIN D
FI20012242A0 (en) New pharmaceutical compounds
NO20015694D0 (en) Packing
FI20021406A0 (en) Use of such compounds
NO20015575D0 (en) Encapsulation of liquid crystals
UA4857S (en) PACKING BOX
FIU20010427U0 (en) Sovetov Packing

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABGENOMICS COOPERATIEF U.A., NL

FC2A Withdrawal, rejection or dismissal of laid open patent application